Next Article in Journal
Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding
Next Article in Special Issue
Immunoglobulin M Paraproteinaemias
Previous Article in Journal
Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance
Previous Article in Special Issue
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma
Review

Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All

1
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
2
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
*
Author to whom correspondence should be addressed.
Cancers 2020, 12(6), 1554; https://doi.org/10.3390/cancers12061554
Received: 18 April 2020 / Revised: 7 June 2020 / Accepted: 10 June 2020 / Published: 12 June 2020
(This article belongs to the Special Issue The Asymptomatic Version of Myeloma: MGUS and Smoldering Myeloma)
Monoclonal Gammopathy of Undetermined Significance (MGUS) is considered to be a benign precursor condition that may progress to a lymphoproliferative disease or multiple myeloma. Most patients do not progress to an overt condition, but nevertheless, MGUS is associated with a shortened life expectancy and, in a minority of cases, a number of co-morbid conditions that include an increased fracture risk, renal impairment, peripheral neuropathy, secondary immunodeficiency, and cardiovascular disease. This review aims to consolidate current evidence for the significance of these co-morbidities before considering how best to approach these symptoms and signs, which are often encountered in primary care or within a number of specialties in secondary care. View Full-Text
Keywords: MGUS; multiple myeloma; paraprotein; neuropathy; fracture; MGRS; osteoporosis MGUS; multiple myeloma; paraprotein; neuropathy; fracture; MGRS; osteoporosis
Show Figures

Figure 1

MDPI and ACS Style

Lomas, O.C.; Mouhieddine, T.H.; Tahri, S.; Ghobrial, I.M. Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All. Cancers 2020, 12, 1554. https://doi.org/10.3390/cancers12061554

AMA Style

Lomas OC, Mouhieddine TH, Tahri S, Ghobrial IM. Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All. Cancers. 2020; 12(6):1554. https://doi.org/10.3390/cancers12061554

Chicago/Turabian Style

Lomas, Oliver C., Tarek H. Mouhieddine, Sabrin Tahri, and Irene M. Ghobrial. 2020. "Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All" Cancers 12, no. 6: 1554. https://doi.org/10.3390/cancers12061554

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop